December 27, 2019
Lannett Company Inc. is recalling nearly 17,000 bottles of levetiracetam oral solution over concerns about microbial contamination, according to the December 25, 2019, US Food and Drug Administration (FDA) Enforcement Report.
The recall is for levetiracetam oral solution, 100 mg/mL, 473-mL bottles (NDC 54838-0548-80) from lot 2190A and 2191A (Exp. 7/21). The bottles were distributed throughout the United States.
Lannett Company initiated the voluntary recall December 6, 2019. At press time, the FDA had not yet issued a recall classification.
Levetiracetam is a prescription anticonvulsant used to treat seizures.